Abstract
Arsenic causes oxidative stress in cultured animal and human cells, and it is a well-documented human carcinogen. We conducted a hospital-based case–control study including 167 cases of urothelial carcinoma (UC) and 334 age- and gender-matched healthy controls to evaluate the relationships between urinary arsenic profiles, urinary 8-hydroxydeoxyguanosine (8-OHdG) levels, and human 8-oxoguanine DNA glycosylase (hOGG1) genotypes and UC. The urinary arsenic species were analyzed by high-performance liquid chromatography and hydride generator-atomic absorption spectrometry. Genotyping for hOGG1 (Ser326Cys) and hOGG1 (−15C>G) was performed using the Sequenom MassARRAY platform with iPLEX Gold chemistry. Urinary 8-OHdG was measured with high-sensitivity enzyme-linked immunosorbent assay kits. The results indicated that the hOGG1 326 Cys/Cys genotype and the hOGG1 −15C>G G/G genotype were associated with an increased risk of UC (OR [95 % CI] 1.57 [1.04–2.35] and 1.57 [1.04–2.35], respectively). Participants with high urinary total arsenic, regardless of the haplotype of hOGG1 Ser326Cys and the −15C>G polymorphism, had significantly higher urinary 8-OHdG compared to participants with low urinary total arsenic. This is the first study to investigate the joint effects of high urinary total arsenic or inefficient arsenic methylation capacity indices, and the high-risk G–G haplotype of hOGG1 on the risk of UC. The findings are especially meaningful for participants with risk factors such as high urinary total arsenic, inefficient arsenic methylation indices, high urinary 8-OHdG, and the high-risk G–G haplotype of hOGG1 which are all associated with an increased UC risk.
Similar content being viewed by others
References
Arizono K, Osada Y, Kuroda Y (2008) DNA repair gene hOGG1 codon 326 and XRCC1 codon 399 polymorphisms and bladder cancer risk in a Japanese population. Jpn J Clin Oncol 38:186–191
Bach J, Sampayo-Reyes A, Marcos R, Hernandez A (2014) Ogg1 genetic background determines the genotoxic potential of environmentally relevant arsenic exposures. Arch Toxicol 88:585–596
Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263–265
Bhattacharjee P, Banerjee M, Giri AK (2013) Role of genomic instability in arsenic-induced carcinogenicity. A review. Environ Int 53:29–40
Bravard A, Vacher M, Moritz E, Vaslin L, Hall J, Epe B, Radicella JP (2009) Oxidation status of human OGG1-S326C polymorphic variant determines cellular DNA repair capacity. Cancer Res 69:3642–3649
Burger M, Catto JW, Dalbagni G, Grossman HB, Herr H, Karakiewicz P, Kassouf W, Kiemeney LA, La VC, Shariat S, Lotan Y (2013) Epidemiology and risk factors of urothelial bladder cancer. Eur Urol 63:234–241
Chen CJ, Kuo TL, Wu MM (1988) Arsenic and cancers. Lancet 1:414–415
Chen YC, Amarasiriwardena CJ, Hsueh YM, Christiani DC (2002) Stability of arsenic species and insoluble arsenic in human urine. Cancer Epidemiol Biomark Prev 11:1427–1433
Chen CJ, Wang SL, Chiou JM, Tseng CH, Chiou HY, Hsueh YM, Chen SY, Wu MM, Lai MS (2007) Arsenic and diabetes and hypertension in human populations: a review. Toxicol Appl Pharmacol 222:298–304
Chiang CI, Huang YL, Chen WJ, Shiue HS, Huang CY, Pu YS, Lin YC, Hsueh YM (2014) XRCC1 Arg194Trp and Arg399Gln polymorphisms and arsenic methylation capacity are associated with urothelial carcinoma. Toxicol Appl Pharmacol 279:373–379
Chiou HY, Huang WI, Su CL, Chang SF, Hsu YH, Chen CJ (1997) Dose-response relationship between prevalence of cerebrovascular disease and ingested inorganic arsenic. Stroke 28:1717–1723
Chung CJ, Huang CJ, Pu YS, Su CT, Huang YK, Chen YT, Hsueh YM (2008) Urinary 8-hydroxydeoxyguanosine and urothelial carcinoma risk in low arsenic exposure area. Toxicol Appl Pharmacol 226:14–21
Flora SJ (2011) Arsenic-induced oxidative stress and its reversibility. Free Radic Biol Med 51:257–281
Fujihara J, Soejima M, Yasuda T, Koda Y, Kunito T, Iwata H, Tanabe S, Takeshita H (2011) Polymorphic trial in oxidative damage of arsenic exposed Vietnamese. Toxicol Appl Pharmacol 256:174–178
Gangwar R, Ahirwar D, Mandhani A, Mittal RD (2009) Do DNA repair genes OGG1, XRCC3 and XRCC7 have an impact on susceptibility to bladder cancer in the North Indian population? Mutat Res 680:56–63
Hinhumpatch P, Navasumrit P, Chaisatra K, Promvijit J, Mahidol C, Ruchirawat M (2013) Oxidative DNA damage and repair in children exposed to low levels of arsenic in utero and during early childhood: application of salivary and urinary biomarkers. Toxicol Appl Pharmacol 273:569–579
Hirano T, Kawai K, Ootsuyama Y, Kasai H (2006) Fragmentation of the DNA repair enzyme, OGG1, in mouse nonparenchymal liver cells by arsenic compounds. Genes Environ 28:62–67
Hosmer DW, Lemeshow S (1992) Confidence interval estimation of interaction. Epidemiology 3:452–456
Hsueh YM, Huang YL, Huang CC, Wu WL, Chen HM, Yang MH, Lue LC, Chen CJ (1998) Urinary levels of inorganic and organic arsenic metabolites among residents in an arseniasis-hyperendemic area in Taiwan. J Toxicol Environ Health A 54:431–444
Hsueh YM, Hsu MK, Chiou HY, Yang MH, Huang CC, Chen CJ (2002) Urinary arsenic speciation in subjects with or without restriction from seafood dietary intake. Toxicol Lett 133:83–91
Huang CY, Su CT, Chung CJ, Pu YS, Chu JS, Yang HY, Wu CC, Hsueh YM (2012) Urinary total arsenic and 8-hydroxydeoxyguanosine are associated with renal cell carcinoma in an area without obvious arsenic exposure. Toxicol Appl Pharmacol 262:349–354
Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics, 2010. CA Cancer J Clin 60:277–300
Karahalil B, Kocabas NA, Ozcelik T (2006) DNA repair gene polymorphisms and bladder cancer susceptibility in a Turkish population. Anticancer Res 26:4955–4958
Kim KY, Han W, Noh DY, Kang D, Kwack K (2013) Impact of genetic polymorphisms in base excision repair genes on the risk of breast cancer in a Korean population. Gene 532:192–196
Liang PI, Li WM, Wang YH, Wu TF, Wu WR, Liao AC, Shen KH, Wei YC, Hsing CH, Shiue YL, Huang HY, Hsu HP, Chen LT, Lin CY, Tai C, Lin CM, Li CF (2012) HuR cytoplasmic expression is associated with increased cyclin A expression and poor outcome with upper urinary tract urothelial carcinoma. BMC Cancer 12:611
Ma L, Chu H, Wang M, Shi D, Zhong D, Li P, Tong N, Yin C, Zhang Z (2012) hOGG1 Ser326Cys polymorphism is associated with risk of bladder cancer in a Chinese population: a case-control study. Cancer Sci 103:1215–1220
Mei N, Kunugita N, Hirano T, Kasai H (2002) Acute arsenite-induced 8-hydroxyguanine is associated with inhibition of repair activity in cultured human cells. Biochem. Biophys. Res. Commun. 297:924–930
Mittal RD, Mandal RK, Gangwar R (2012) Base excision repair pathway genes polymorphism in prostate and bladder cancer risk in North Indian population. Mech Ageing Dev 133:127–132
Nesnow S, Roop BC, Lambert G, Kadiiska M, Mason RP, Cullen WR, Mass MJ (2002) DNA damage induced by methylated trivalent arsenicals is mediated by reactive oxygen species. Chem Res Toxicol 15:1627–1634
Osmond MJ, Kunz BA, Snow ET (2010) Age and exposure to arsenic alter base excision repair transcript levels in mice. Mutagenesis 25:517–522
Pu YS, Yang SM, Huang YK, Chung CJ, Huang SK, Chiu AW, Yang MH, Chen CJ, Hsueh YM (2007) Urinary arsenic profile affects the risk of urothelial carcinoma even at low arsenic exposure. Toxicol Appl Pharmacol 218:99–106
Qin XJ, Hudson LG, Liu W, Ding W, Cooper KL, Liu KJ (2008) Dual actions involved in arsenite-induced oxidative DNA damage. Chem Res Toxicol 21:1806–1813
Ramaniuk VP, Nikitchenko NV, Savina NV, Kuzhir TD, Rolevich AI, Krasny SA, Sushinsky VE, Goncharova RI (2014) Polymorphism of DNA repair genes OGG1, XRCC1, XPD and ERCC6 in bladder cancer in Belarus. Biomarkers 19:509–516
Roy M, Sinha D, Mukherjee S, Biswas J (2011) Curcumin prevents DNA damage and enhances the repair potential in a chronically arsenic-exposed human population in West Bengal, India. Eur J Cancer Prev 20:123–131
Ruiz-Ramos R, Lopez-Carrillo L, Rios-Perez AD, De Vizcaya-Ruiz A, Cebrian ME (2009) Sodium arsenite induces ROS generation, DNA oxidative damage, HO-1 and c-Myc proteins, NF-kappaB activation and cell proliferation in human breast cancer MCF-7 cells. Mutat Res 674:109–115
Saito S, Yamauchi H, Hasui Y, Kurashige J, Ochi H, Yoshida K (2000) Quantitative determination of urinary 8-hydroxydeoxyguanosine (8-OH-dg) by using ELISA. Res Commun Mol Pathol Pharmacol 107:39–44
Simonelli V, Camerini S, Mazzei F, Van LB, Allione A, D’Errico M, Barone F, Minoprio A, Ricceri F, Guarrera S, Russo A, Dalhus B, Crescenzi M, Hubscher U, Bjoras M, Matullo G, Dogliotti E (2013) Genotype-phenotype analysis of S326C OGG1 polymorphism: a risk factor for oxidative pathologies. Free Radic Biol Med 63:401–409
Srivastava K, Srivastava A, Mittal B (2010) Polymorphisms in ERCC2, MSH2, and OGG1 DNA repair genes and gallbladder cancer risk in a population of Northern India. Cancer 116:3160–3169
Srivastava K, Srivastava A, Kumar A, Mittal B (2011) Gallbladder cancer predisposition: a multigenic approach to DNA-repair, apoptotic and inflammatory pathway genes. PLoS ONE 6:e16449
Tseng CH (2008) Cardiovascular disease in arsenic-exposed subjects living in the arseniasis-hyperendemic areas in Taiwan. Atherosclerosis 199:12–18
WHO (2008) Guidelines for drinking water quality: incorporating First and second addenda to third edition. Vol 1-recommidations. WHO Press, Geneva? Ref Type: Report
Xu Y, Wang Y, Zheng Q, Li X, Li B, Jin Y, Sun X, Sun G (2008) Association of oxidative stress with arsenic methylation in chronic arsenic-exposed children and adults. Toxicol Appl Pharmacol 232:142–149
Yamane A, Kohno T, Ito K, Sunaga N, Aoki K, Yoshimura K, Murakami H, Nojima Y, Yokota J (2004) Differential ability of polymorphic OGG1 proteins to suppress mutagenesis induced by 8-hydroxyguanine in human cell in vivo. Carcinogenesis 25:1689–1694
Yamauchi H, Aminaka Y, Yoshida K, Sun G, Pi J, Waalkes MP (2004) Evaluation of DNA damage in patients with arsenic poisoning: urinary 8-hydroxydeoxyguanine. Toxicol Appl Pharmacol 198:291–296
Zhang Y, He BS, Pan YQ, Xu YQ, Wang SK (2011) Association of OGG1 Ser326Cys polymorphism with colorectal cancer risk: a meta-analysis. Int J Colorectal Dis 26:1525–1530
Zhong D, Li G, Long J, Wu J, Hu Y (2012a) The hOGG1Ser326Cys polymorphism and increased lung cancer susceptibility in Caucasians: an updated meta-analysis. Sci Rep 2:548
Zhong DY, Chu HY, Wang ML, Ma L, Shi DN, Zhang ZD (2012b) Meta-analysis demonstrates lack of association of the hOGG1 Ser326Cys polymorphism with bladder cancer risk. Genet Mol Res 11:3490–3496
Acknowledgments
This study was supported by grants from the National Science Council of the Republic of China (NSC 86-2314-B-038-038, NSC 87-2314-B-038-029, NSC-88-2314-B-038-112, NSC-89-2314-B038-049, SC-89-2320-B038-013, NSC-90-2320-B-038-021, NSC-91-3112-B-038-0019, NSC-92-3112-B-038-001, NSC-93-3112-B-038-001, NSC-94-2314-B-038-023, NSC-95-2314-B-038-007, NSC-96-2314-B038-003, NSC-97-2314-B-038-015-MY3 (1-3), NSC-97-2314-B-038-015-MY3 (2-3), NSC-97-2314-B-038-015-MY3 (3-3)), NSC 100-2314-B-038 -026, NSC 101-2314-B-038 -051-MY3 (1-3), NSC 101-2314-B-038 -051-MY3 (2-3), NSC 101-2314-B-038 -051-MY3 (3-3), MOST103-2314-B-038-021-MY2 (1-2).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest.
Rights and permissions
About this article
Cite this article
Huang, CY., Pu, YS., Shiue, HS. et al. Polymorphisms of human 8-oxoguanine DNA glycosylase 1 and 8-hydroxydeoxyguanosine increase susceptibility to arsenic methylation capacity-related urothelial carcinoma. Arch Toxicol 90, 1917–1927 (2016). https://doi.org/10.1007/s00204-015-1590-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00204-015-1590-x